{
  "id": "62755c2a56bf9aee6f000001",
  "type": "list",
  "question": "Which are the types of cancer that c-Myc is associated with?",
  "ideal_answer": "The types of cancer that c-Myc is associates with are breast cancer, non-small-cell lung cancer and pancreatic ductal adenocarcinoma.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/19174520",
    "http://www.ncbi.nlm.nih.gov/pubmed/20737197",
    "http://www.ncbi.nlm.nih.gov/pubmed/20697349",
    "http://www.ncbi.nlm.nih.gov/pubmed/2227545",
    "http://www.ncbi.nlm.nih.gov/pubmed/1493439",
    "http://www.ncbi.nlm.nih.gov/pubmed/28623290",
    "http://www.ncbi.nlm.nih.gov/pubmed/33390842",
    "http://www.ncbi.nlm.nih.gov/pubmed/3332004",
    "http://www.ncbi.nlm.nih.gov/pubmed/15929079",
    "http://www.ncbi.nlm.nih.gov/pubmed/24646303",
    "http://www.ncbi.nlm.nih.gov/pubmed/25306215",
    "http://www.ncbi.nlm.nih.gov/pubmed/30226440",
    "http://www.ncbi.nlm.nih.gov/pubmed/18190704",
    "http://www.ncbi.nlm.nih.gov/pubmed/29263157",
    "http://www.ncbi.nlm.nih.gov/pubmed/30224636",
    "http://www.ncbi.nlm.nih.gov/pubmed/28741879",
    "http://www.ncbi.nlm.nih.gov/pubmed/31144531",
    "http://www.ncbi.nlm.nih.gov/pubmed/26954716",
    "http://www.ncbi.nlm.nih.gov/pubmed/28160502",
    "http://www.ncbi.nlm.nih.gov/pubmed/8353142",
    "http://www.ncbi.nlm.nih.gov/pubmed/3670047"
  ],
  "snippets": [
    {
      "text": "As a transcription factor and proto-oncogene, MYC is known to be deregulated in a variety of tumors, including breast cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33390842",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "a tumor suppressor role of miR-376a in NSCLC by targeting c-Myc",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28741879",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These results provide strong justification for eventual clinical evaluation of anti-Myc drugs as potential chemotherapeutic agents for the treatment of PDA.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25306215",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONTEXT: c-Myc plays a key role in glioma cancer stem cell ma",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646303",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The proto-oncogene c-Myc has a pivotal function in growth control, differentiation, and apoptosis and is frequently affected in human cancer, including breast cancer. U",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28160502",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "or types exhibiting c-myc as a \"progressor\" gene include breast, colon, small cell lung carcinoma, as well as ovarian cancer, lymphomas, and squamous cell carcinomas. The c-myc on",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8353142",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28623290",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Pancreatic adenocarcinoma is a highly malignant cancer that often involves a deregulation of c-Myc",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30224636",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Background: c-Myc is overexpressed in different types of cancer, including thyroid cancer, and has been considered",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30226440",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The tumor types exhibiting c-myc as a \"progressor\" gene include breast, colon, small cell lung carcinoma, as well as ovarian cancer, lymphomas, and squamous cell carcinomas",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8353142",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The tumor types exhibiting c-myc as a \"progressor\" gene include breast, colon, small cell lung carcinoma, as well as ovarian cancer, lymphomas, and squamous cell carcinomas.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8353142",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Different types of c-myc involvement are associated with specific types of lymphoma: there are differences between endemic, sporadic and ileocecal Burkitt's lymphoma as well as between those and primary extranodal large cell lymphoma and large cell lymphoma which has progressed.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1493439",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The association of c-myc rearrangements with specific types of human non-Hodgkin's lymphomas.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1493439",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "In a large number of cases it was determined that amplified oncogenes occurred in 10 to 20% of tumors with the following specific associations: c-myc in adenocarcinomas, squamous carcinomas and sarcomas but not hematologic malignancies; c-erbB2 in adenocarcinomas, particularly breast cancers; c-erbB1 in squamous carcinomas; N-myc in neuroblastomas.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/3670047",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The upregulation or mutation of C-MYC has been observed in gastric, colon, breast, and lung tumors and in Burkitt's lymphoma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20737197",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The involvement of c-myc in mouse plasmacytomas and human Burkitt's lymphoma is well known: due to chromosomal translocation c-myc comes under the influence of regulatory elements of immunoglobulin genes, leading to increased expression of the gene and proliferation of the cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1493439",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A small number of cases suggested other specific associations: amplified c-myb in breast cancers; amplified c-ras-Ha and c-ras-Ki in ovarian carcinomas.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/3670047",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In small cell lung cancer, high levels of myc gene expression are usually associated with gene amplification, and not uncommonly there is rearrangement of some of the amplified copies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/3332004",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: MYC is amplified in approximately 15% of breast cancers (BCs) and is associated with p",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26954716",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26954716",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Several lung cancers of both small cell and non-small cell type (including adeno- and squamous cell lung cancer) express the proto-oncogenes c-, N-, or L-myc, and in some cases more than one of these family members.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/3332004",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "c-MYC Asn11Ser is associated with increased risk for familial breast cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15929079",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "Breast cancer, breast cancer, Non-small-cell lung cancer, NSCLC, Pancreatic ductal adenocarcinoma, pda"
}